Regimens for MA offered by Canadian physicians in 2012 who responded to the 2013 cross-sectional survey of abortion provision in the United States and Canada: N = 61; one physician did not respond to questions about MA regimens.
MA REGIMEN | PHYSICIANS USING METHOD, N (%) |
---|---|
Method of MA | |
• Misoprostol only | 9 (14.8) |
• IM methotrexate 50 mg/m2 of body surface and misoprostol | 42 (68.9) |
• Methotrexate 50 mg orally and misoprostol | 10 (16.3) |
Initial dose of misoprostol | |
• 400 μg | 4 (6.6) |
• 800 μg | 57 (93.4) |
Misoprostol route | |
• Vaginal | 47 (77.0) |
• Sublingual | 6 (9.8) |
• Buccal | 8 (13.1) |
Misoprostol timing | |
• 1 or 2 d after methotrexate | 12 (19.7) |
• 3 d after methotrexate | 11 (18.0) |
• 4–6 d after methotrexate | 18 (29.5) |
• Other range (all ≤ 7 d) | 10 (16.3) |
• > 7 days after methotrexate | 1 (1.6) |
• Misoprostol only | 9 (14.8) |
Location misoprostol is taken | |
• At home | 58 (95.1) |
• At medical facility | 3 (4.9) |
Repeat dose of misoprostol | |
• Dispensed routinely | 57 (93.4) |
• Dispensed only as needed | 3 (4.9) |
• Never given | 1 (1.6) |
Total | 61 (100.0) |
IM—intramuscular, MA—medical abortion.